Research ArticleCancer Immunotherapy

Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer

See allHide authors and affiliations

Science Signaling  02 Jan 2018:
Vol. 11, Issue 511, eaan0790
DOI: 10.1126/scisignal.aan0790
PDF Container

Navigate This Article